ATRA
Atara Biotherapeutics Inc
Price:  
8.23 
USD
Volume:  
439,021.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Atara WACC - Weighted Average Cost of Capital

The WACC of Atara Biotherapeutics Inc (ATRA) is 15.7%.

The Cost of Equity of Atara Biotherapeutics Inc (ATRA) is 8.30%.
The Cost of Debt of Atara Biotherapeutics Inc (ATRA) is 28.45%.

Range Selected
Cost of equity 6.80% - 9.80% 8.30%
Tax rate -% - -% -%
Cost of debt 7.00% - 49.90% 28.45%
WACC 6.9% - 24.4% 15.7%
WACC

Atara WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.64 0.87
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 9.80%
Tax rate -% -%
Debt/Equity ratio 0.58 0.58
Cost of debt 7.00% 49.90%
After-tax WACC 6.9% 24.4%
Selected WACC 15.7%